RECOMBINANT HUMAN HYALURONIDASE-FACILITATED SUBCUTANEOUS IMMUNOGLOBULIN FOR IDIOPATHIC INFLAMMATORY MYOSITIS: A MULTICENTER OBSERVATIONAL STUDY

被引：0
|
作者：
Palermo, A. [1 ]
Bettiol, A. [1 ]
Urban, M. L. [1 ]
Barilaro, A. [2 ]
Danieli, M. G. [3 ]
Capassoni, M. [4 ]
Guiducci, S. [4 ]
Campochiaro, C. [5 ,6 ]
Dagna, L. [5 ,6 ]
Canti, V. [7 ,8 ]
Rovere-Querini, P. [7 ,8 ]
Cardelli, C. [9 ]
Mosca, M. [9 ]
Emmi, G. [1 ]
机构：
[1] Univ Firenze, Dept Expt & Clin Med, Florence, Italy
[2] Careggi Univ Hosp, Neurol Unit 2, Florence, Italy
[3] Polytech Univ Marche, Dept Clin & Mol Sci, Clin Medica, Torrette Di Ancona, Italy
[4] Univ Firenze, Dept Clin & Expt Med, Rheumatol Unit, Florence, Italy
[5] IRCCS Osped San Raffaele, Milan, Italy
[6] Univ Vita Salute San Raffaele, Immunol Unit Rheumatol Allergy & Rare Dis, Milan, Italy
[7] IRCCS San Raffaele Inst, Milan, Italy
[8] Univ Vita Salute San Raffaele, Div Immunol Transplantat & Infect Dis, Milan, Italy
[9] Univ Pisa, Dept Clin & Expt Med, Rheumatol Unit, Pisa, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.4827
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0922
引用
收藏
页码：761 / 761
页数：1
相关论文
共 50 条
  • [21] Self-administered hyaluronidase-facilitated subcutaneous immunoglobulin therapy in complicated primary antibody deficiencies
    Danieli, Maria Giovanna
    Pulvirenti, Federica
    Rocchi, Valeria
    Morariu, Ramona
    Quinti, Isabella
    IMMUNOTHERAPY, 2016, 8 (09) : 995 - 1002
  • [22] REAL-WORLD PEDIATRIC EXPERIENCE WITH HYALURONIDASE-FACILITATED SUBCUTANEOUS IMMUNOGLOBULIN (IGHY) INFUSION PARAMETERS
    Gruenemeier, P.
    Ernst, C.
    White, C.
    Duff, K.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S98 - S98
  • [23] Population pharmacokinetics of immunoglobulin G after intravenous, subcutaneous, or hyaluronidase-facilitated subcutaneous administration in immunoglobulin-naive patients with primary immunodeficiencies
    Li, Zhaoyang
    Follman, Kristin
    Freshwater, Ed
    Engler, Frank
    Yel, Leman
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 128
  • [24] POST-AUTHORIZATION SAFETY STUDY OF HYALURONIDASE-FACILITATED SUBCUTANEOUS IMMUNOGLOBULIN 10% TREATMENT IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES
    Rubinstein, A.
    Bridges, T.
    McNeil, D.
    Tachdjian, R.
    Wedner, H.
    Wasserman, R.
    Leibl, H.
    Rabbat, C.
    Honigberg, R.
    Yel, L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S71 - S71
  • [25] LONG-TERM SAFETY, EFFICACY, AND TOLERABILITY OF RECOMBINANT HUMAN HYALURONIDASE-FACILITATED SUBCUTANEOUS INFUSION OF IMMUNOGLOBULIN G IN PATIENTS AGED ≥16 YEARS WITH PRIMARY IMMUNODEFICIENCIES
    Wasserman, R. L.
    Stein, M.
    Kobrynski, L.
    Gupta, S.
    Grant, J.
    Rubinstein, A.
    Engl, W.
    McCoy, B.
    Leibl, H.
    Yel, L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 115 (05) : A103 - A103
  • [26] RETROSPECTIVE REVIEW OF NEEDLE LENGTH AND CLINICAL CONSIDERATIONS DURING HYALURONIDASE-FACILITATED SUBCUTANEOUS ADMINISTRATION OF IMMUNOGLOBULIN (IGHY)
    Gruenemeier, P.
    Ernst, C.
    Palagashvili, T.
    Duff, K.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S99 - S99
  • [27] Cost-effectiveness of recombinant human hyaluronidase-facilitated subcutaneous versus intravenous rehydration in children with mild to moderate dehydration
    Mace, Sharon E.
    Harb, George
    Friend, Keith
    Turpin, Robin
    Armstrong, Edward P.
    Lebel, Francois
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2013, 31 (06): : 928 - 934
  • [28] Efficacy and safety of hyaluronidase-facilitated subcutaneous immunoglobulin 10% in US pediatric patients with primary immunodeficiency disease
    Patel, Niraj
    Walter, Jolan
    Wasserman, Richard
    Rubinstein, Arye
    Atkinson, T. Prescott
    Shepherd, Meagan
    Greco, Erin
    Russo-Schwarzbaum, Sharon
    Duff, Kimberly
    Mccoy, Barbara
    Chu, Liang-Hui
    Li, Zhaoyang
    Yel, Leman
    CLINICAL IMMUNOLOGY, 2023, 250 : 148 - 149
  • [29] EUROPEAN POSTAUTHORIZATION SAFETY STUDY ON LONG-TERM HYALURONIDASE-FACILITATED SUBCUTANEOUS IMMUNOGLOBULIN IN PRIMARY IMMUNODEFICIENCY DISEASES: INTERIM ANALYSIS
    Ellerbroek, Pauline M.
    van Paassen, Pieter
    Hanitsch, Leif
    Plebani, Alessandro
    Schmidt, Reinhold E.
    van Hagen, P. Martin
    Wang, Ping
    Fielhauer, Katharina
    Leibl, Heinz
    Chavan, Shailesh
    Yel, Leman
    MUSCLE & NERVE, 2020, 62 : S67 - S68
  • [30] Interim Analysis of the Global Post Authorization Safety Study of Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% Treatment in Patients With Primary Immunodeficiency Diseases
    Rubinstein, Arye
    Bridges, Tracy
    McNeil, Donald
    Tachdjian, Raffi
    Wedner, H. James
    Wasserman, Richard L.
    Leibl, Heinz
    Rabbat, Christopher
    Yel, Leman
    JOURNAL OF CLINICAL IMMUNOLOGY, 2018, 38 (03) : 378 - 378
12345